Tag: Drug recalls

While the vast majority of drugs remain on the market, one study of drugs approved between 1990 and 2009 found that 4.2% were eventually withdrawn for safety reasons. However, answering the question of what percent of FDA approved drugs are pulled requires understanding the complex landscape of post-market drug safety actions, which includes not just full withdrawals but also recalls and black box warnings.

According to the U.S. Food and Drug Administration (FDA), numerous drugs are recalled or removed from the market annually for various reasons, making it critical for patients to stay informed about what prescriptions are being stopped. Recent actions, such as the FDA crackdown on certain off-brand weight-loss drugs and the withdrawal of specific generic lots, highlight a constantly evolving regulatory and safety landscape for consumers.

In 2020, the FDA requested the complete withdrawal of all ranitidine products from the U.S. market, fueling widespread consumer concern about NDMA contamination. This action, along with earlier recalls of blood pressure drugs, raised a crucial question for millions of patients: **What medications have NDMA in them?**

Metformin is a widely prescribed medication, with tens of millions of prescriptions written annually in the US. Following a series of recalls involving N-Nitrosodimethylamine (NDMA) impurities in certain products, many patients have asked: **Is NDMA still in metformin?**

Since 2018, regulatory bodies like the FDA have overseen recalls of numerous medications contaminated with N-Nitrosodimethylamine, or NDMA. However, there is no single drug name for NDMA, as it is not an active ingredient but an impurity with probable carcinogenic properties.

In November 2000, following a public health advisory from the FDA, Ornade, a popular cold and allergy medication, was voluntarily removed from the market by its manufacturer. The central reason **why was Ornade discontinued** was the association of one of its key ingredients, phenylpropanolamine (PPA), with a rare but serious risk of hemorrhagic stroke.

In February 2025, NeilMed Pharmaceuticals voluntarily recalled over 89,000 bottles of its NasoGel Spray due to a potential “microbial failure,” causing concern among consumers asking: which nasal spray was recalled?. Product recalls are a critical safety measure used by the U.S. Food and Drug Administration (FDA) to protect public health from potentially dangerous or defective medications and medical devices. This article details the specific products involved in recent nasal spray recalls and the reasons behind them.

According to the FDA, dozens of over-the-counter eye drop products were recalled between 2023 and 2025 due to contamination risks and manufacturing violations. This has caused concern among consumers, leading many to ask, **which eye drops are recalled?**